Hypoxic pulmonary vasoconstriction: mechanisms and controversies.
about
The human side of hypoxia-inducible factorPulmonary blast injury in mice: a novel model for studying blast injury in the laboratory using laser-induced stress waves.Hypoxic pulmonary vasodilation: a paradigm shift with a hydrogen sulfide mechanismThe NADPH oxidase subunit NOX4 is a new target gene of the hypoxia-inducible factor-1.Endothelial and smooth muscle cell ion channels in pulmonary vasoconstriction and vascular remodelingInhibition of hypoxic pulmonary vasoconstriction of rats by carbon monoxide.Superoxide differentially controls pulmonary and systemic vascular tone through multiple signalling pathwaysPulmonary vasodilation by acetazolamide during hypoxia is unrelated to carbonic anhydrase inhibition.Acute pulmonary edema due to hypoxia during a difficult intubation in a rheumatoid arthritis patientHypoxia. 4. Hypoxia and ion channel functionEndothelin-1 contributes to increased NFATc3 activation by chronic hypoxia in pulmonary arteries.A mitochondrial redox oxygen sensor in the pulmonary vasculature and ductus arteriosusHypoxia reduces KCa channel activity by inducing Ca2+ spark uncoupling in cerebral artery smooth muscle cellsSpatial-temporal dynamics of pulmonary blood flow in the healthy human lung in response to altered FI(O2).Involvement of gap junctions between smooth muscle cells in sustained hypoxic pulmonary vasoconstriction development: a potential role for 15-HETE and 20-HETEGap junctions support the sustained phase of hypoxic pulmonary vasoconstriction by facilitating calcium sensitization.The increase in pulmonary arterial pressure caused by hypoxia depends on iron status.Mechanisms of hypoxic pulmonary vasoconstriction and their roles in pulmonary hypertension: new findings for an old problemEffects of dimethylarginine dimethylaminohydrolase-1 overexpression on the response of the pulmonary vasculature to hypoxia.Mitochondrial reactive oxygen species regulate hypoxic signaling.HIF and pulmonary vascular responses to hypoxia.The vasorelaxing effect of hydrogen sulfide on isolated rat aortic rings versus pulmonary artery ringsRegulation of the pulmonary circulation in the fetus and newborn.Oxygen dependence of metabolism and cellular adaptation in vertebrate muscles: a review.Rho GTPases in the regulation of pulmonary vascular barrier function.Hypoxia-dependent reactive oxygen species signaling in the pulmonary circulation: focus on ion channels.Pulmonary vascular dysfunction in ARDS.Lung Circulation.Mitochondria control acute and chronic responses to hypoxia.Mitochondria-dependent regulation of Kv currents in rat pulmonary artery smooth muscle cells.Role of ROS signaling in differential hypoxic Ca2+ and contractile responses in pulmonary and systemic vascular smooth muscle cells.Analysis of pulmonary vasodilator responses to SB-772077-B [4-(7-((3-amino-1-pyrrolidinyl)carbonyl)-1-ethyl-1H-imidazo(4,5-c)pyridin-2-yl)-1,2,5-oxadiazol-3-amine], a novel aminofurazan-based Rho kinase inhibitor.Diacylglycerol regulates acute hypoxic pulmonary vasoconstriction via TRPC6.Sphingosylphosphorylcholine potentiates vasoreactivity and voltage-gated Ca2+ entry via NOX1 and reactive oxygen species.Hypoxic pulmonary vasoconstriction in the absence of pretone: essential role for intracellular Ca2+ release.The Rho kinase inhibitor azaindole-1 has long-acting vasodilator activity in the pulmonary vascular bed of the intact chest rat.HIF-1 alpha-induced up-regulation of miR-9 contributes to phenotypic modulation in pulmonary artery smooth muscle cells during hypoxia.Heterogeneity of hypoxia-mediated decrease in I(K(V)) and increase in [Ca2+](cyt) in pulmonary artery smooth muscle cells.Mechanisms of the prostaglandin F2alpha-induced rise in [Ca2+]i in rat intrapulmonary arteries.Hydrogen sulfide mediates hypoxic vasoconstriction through a production of mitochondrial ROS in trout gills.
P2860
Q24646951-6226BB2B-2483-4158-9A7D-FA7DAEC21819Q33568717-73C0DBC7-D089-46D5-A8D0-0ACB056802FCQ33589523-1E4951BD-9B5C-4708-B728-6B64D9A68A49Q33907086-859B4755-DDED-4956-BC56-D17CEB0633A4Q33925149-12F1EC81-4B2D-45C3-944A-29B5E6439056Q34159685-B0892E19-635F-47A7-89F1-06AA6C8E6C04Q34410305-C0FF0548-0AF7-4C69-A0D9-7626F918032EQ34570393-FAB13462-6566-458F-9EA9-312383DDFCC6Q34973991-20F3EC34-CBFB-4D6C-9688-79DC84CDA65BQ34979263-D5D3D1DF-8F61-4761-A39E-81E64B9A8A9CQ35159459-0F4F17F4-1A77-42EF-8F38-496D79CD7821Q36436833-03131558-F3A0-49C0-BD96-643ED75E368BQ36456703-B0FAF650-4CC2-4B36-8AE6-9EC9E84789A5Q36531021-E4791DD5-E6FA-4BC1-B21A-781AF297A50DQ36811256-048006C8-FD50-48D6-90EA-EC0C6D5DBE6BQ37032299-B7627C5C-E0CF-463C-84FB-95E58A1664ECQ37127689-6AF79448-30EB-472F-8BA0-B91B7B7C81FBQ37218115-2F7CA223-B1AF-491A-82CC-7FD1AB2272F7Q37297962-7D340D93-DB4F-4692-AEF3-69280583C50DQ37603588-D748D49A-F461-4C60-BF4B-24D3DCFCC21EQ37679350-2414D65F-B2E4-47D5-B416-A06034E78A79Q37727444-AD13F915-0EC8-4184-B053-6120C5EEA300Q37801516-3C0D5253-48CD-4ABD-97CA-4A64B3705118Q37942080-2C92F4AB-4897-423D-8D77-D5ABDC8500D4Q38193703-B39D397E-9930-408D-94A9-65E2B081EBEFQ38302264-B4E4A61D-3545-4CAB-B4A0-DFB699CE9486Q38320363-C5D790DA-F5CD-4C22-9E1A-3C21AE43BBADQ38804579-C5ED3DCC-D146-4A6B-80F9-28A6025A0134Q39192606-BFE4B295-D2F4-4EF9-A8D4-A766EA7C9508Q41268644-667AC968-73A8-41DC-AB22-8E8D14C4EAA6Q41528236-0244787B-7E4D-486E-90DC-E6D962504F01Q42136527-7F5627BB-D396-4CD1-8F95-3176784683E9Q42622621-F8591334-F05A-4AEB-B897-F3E63FBDC937Q43189423-77AED1A3-8294-4C9E-9611-11C4F4B3D018Q43949533-FFA60A52-7D74-4407-BB53-749DFF230179Q43957399-9E0820F6-7AFB-41DF-99C5-01238955204CQ46070238-8E1A1696-EB06-49E4-BBC9-CE9C42847CEFQ46484414-BF9A5793-D150-469A-BCCB-19F8FA41FBE5Q46853014-605BA147-B0D6-4520-BC12-B8312FDBC0A2Q47193771-D976316A-9D45-472F-B85E-A51267F0B2E8
P2860
Hypoxic pulmonary vasoconstriction: mechanisms and controversies.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Hypoxic pulmonary vasoconstriction: mechanisms and controversies.
@ast
Hypoxic pulmonary vasoconstriction: mechanisms and controversies.
@en
type
label
Hypoxic pulmonary vasoconstriction: mechanisms and controversies.
@ast
Hypoxic pulmonary vasoconstriction: mechanisms and controversies.
@en
prefLabel
Hypoxic pulmonary vasoconstriction: mechanisms and controversies.
@ast
Hypoxic pulmonary vasoconstriction: mechanisms and controversies.
@en
P2093
P2860
P1476
Hypoxic pulmonary vasoconstriction: mechanisms and controversies.
@en
P2093
Gregory A Knock
Jeremy P T Ward
Philip I Aaronson
Silke Becker
Tom P Robertson
Tristan H Lewis
Vladimir Snetkov
P2860
P356
10.1113/JPHYSIOL.2005.098855
P407
P577
2005-10-27T00:00:00Z